Search

everythinglearnresearchcommunity

for

Search:↓

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Lespedeza cuneata extract may help treat enlarged prostate.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.